Matthew Mazdyasni's most recent trade in Astrana Health Inc. was a trade of 20,000 Stock Option (right to Buy) done . Disclosure was reported to the exchange on Nov. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Astrana Health Inc | Matthew Mazdyasni | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2025 | 20,000 | 0 | - | - | Stock Option (right to Buy) | |
| Astrana Health Inc | Matthew Mazdyasni | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.20 per share. | 10 Nov 2025 | 20,000 | 34,763 (0%) | 0% | 18.2 | 364,000 | Common Stock |
| Astrana Health Inc | Matthew Mazdyasni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,449 | 14,763 (0%) | 0% | 0 | Common Stock | |
| Astrana Health Inc | Matthew Mazdyasni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 3,564 | 8,314 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Matthew Mazdyasni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 4,750 | 4,750 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Matthew Mazdyasni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 8,500 | 8,500 | - | - | Stock Option (right to buy) |